Overview

Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate

Status:
Not yet recruiting
Trial end date:
2021-06-26
Target enrollment:
Participant gender:
Summary
This study is to evaluate The analgesic effect of intrathecal versus intravenous dexmeditomedine in transurethral resection of the prostate
Phase:
Phase 4
Details
Lead Sponsor:
Tanta University
Treatments:
Dexmedetomidine